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Oxidation of methane by a biological dicopper centre 
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Yatsunyk1,2, Timothy L. Stemmler3 & Amy C. Rosenzweig1,2 
1Department of Biochemistry, Molecular Biology and Cell Biology, 2Department of Chemistry, Northwestern 
University, Evanston, Illinois 60208, USA. 3Department of Biochemistry and Molecular Biology, Wayne State 
University, School of Medicine, Detroit, Michigan 48201, USA. 
 
Abstract 
Vast world reserves of methane gas are underutilized as a feedstock for the production of 
liquid fuels and chemicals owing to the lack of economical and sustainable strategies for the 
selective oxidation of methane to methanol1. Current processes to activate the strong C–H 
bond (104 kcal mol−1) in methane require high temperatures, are costly and inefficient, and 
produce waste2. In nature, methanotrophic bacteria perform this reaction under ambient 
conditions using metalloenzymes called methane monooxygenases (MMOs). MMOs thus 
provide the optimal model for an efficient, environmentally sound catalyst3. There are two 
types of MMO. Soluble MMO (sMMO),expressed by several strains of methanotrophs under 
copper-limited conditions, oxidizes methane with a well-characterized catalytic di-iron 
centre4. Particulate MMO (pMMO) is an integral membrane metalloenzyme produced by all 
methanotrophs and is composed of three subunits, pmoA, pmoB and pmoC, arranged in a 
trimeric α3β3γ3 complex5. Despite 20 years of research and the availability of two crystal 
structures, the metal composition and location of the pMMO metal active site are not 
known. Here we show that pMMO activity is dependent on copper, not iron, and that the 
copper active site is located in the soluble domains of the pmoB subunit rather than within 
the membrane. Recombinant soluble fragments of pmoB (spmoB) bind copper and have 
propylene and methane oxidation activities. Disruption of each copper centre in spmoB by 
mutagenesis indicates that the active site is a dicopper centre. These findings help resolve 
the pMMO controversy and provide a promising new approach to developing 
environmentally friendly C–H oxidation catalysts. 
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Three distinct metal centres were identified in the 2.8 Å-resolution structure of pMMO from 
Methylococcus capsulatus (Bath)6,7 (Fig. 1). Two copper centres are located in the soluble regions of 
the pmoB subunit, which form two cupredoxin domains. A dicopper centre with a short Cu–Cu 
distance of 2.5–2.7 Å (refs 8, 9) is coordinated by the highly conserved5 residues His 33, His 137 and 
His 139 and is also observed in pMMO from Methylosinus trichosporium OB3b10. The second site, a 
monocopper centre coordinated by His 48 and His 72, is not conserved in pMMO from M. 
trichosporium OB3b. A third metal centre, occupied by zinc from the crystallization buffer, is located 
within the membrane and is ligated by Asp 156, His 160 and His 173 from pmoC and possibly 
Glu 195 from pmoA (ref. 6). This site contains a copper ion in the structure of M. trichosporium 
OB3b pMMO10. 
The nature of the pMMO metal active site is not established and has been intensely 
controversial11,12. On the basis of electron paramagnetic resonance spectroscopic data, pMMO was 
initially proposed to contain multiple trinuclear copper clusters13,14 In light of the crystallographic 
data, this model was revised to a single catalytic tricopper cluster located at an intramembrane site 
composed of conserved hydrophilic residues15 (Fig. 1). This model also includes the binding of an 
additional ten copper ions to the C-terminal soluble domain of pmoB (ref. 16). Both this 
intramembrane site and the C-terminal domain of pmoB are devoid of metal ions in the crystal 
structures. By contrast, Mössbauer spectroscopic data led to the suggestion that the pMMO active 
site is a di-iron centre located at the intramembrane site occupied by zinc in the structure of M. 
capsulatus (Bath) pMMO (Fig. 1) and by copper in that of M. trichosporium OB3b pMMO (ref. 17). 
To determine the metal requirement for pMMO activity, we first removed the metals from as-
isolated M. capsulatus (Bath) pMMO membranes by treatment with cyanide (Fig. 2a). Before 
cyanide treatment, as-isolated samples had propylene epoxidation activities of 50–200 nmol 
propylene oxide mg−1 min−1. These values are comparable to or higher than values reported by other 
researchers for as-isolated membranes18–20 (Supplementary Table 1). We used membranes rather 
than purified pMMO to resemble the natural environment more closely and to avoid activity loss 
typically observed upon solubilization and purification9. Cyanide treatment completely abolished 
pMMO activity as measured by the propylene epoxidation assay.  
We then titrated stoichiometric amounts of copper and/or iron into the apo pMMO samples and 
assessed the effects on activity. Addition of 2–3 equiv. of copper per 100 kDa pMMO protomer 
restored ~70% of the propylene epoxidation activity (Fig. 3a). We also tested the ability of pMMO 
reconstituted with copper to oxidize methane to methanol. As-isolated pMMO has a specific activity 
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of 22.9 ± 6.1 nmol methanol mg−1 min−1, and apo-pMMO reconstituted with 3 equiv. of copper had an 
activity of 21.7 ± 3.5 nmol methanol mg−1 min−1, restoring greater than 90% of the methane 
oxidation activity (Fig. 3b). By contrast, addition of iron, aerobically or anaerobically, does not 
restore or improve activity if added alone or in combination with copper.  
These experiments demonstrate that copper, not iron17, is the metal at the active site of pMMO. 
The requirement for only 2–3 equiv. of copper indicates that large numbers of copper ions may not 
be necessary for activity, as proposed previously12. Some of the copper associated with the as-
isolated membranes may instead be bound adventitiously. Notably, addition of copper beyond three 
equiv. inhibits pMMO activity. Repeating the cyanide treatment and adding back 2–3 equiv. of 
copper can reverse this inhibition (Supplementary Fig. 1a). The excess copper ions probably react 
with reductant to generate hydrogen peroxide, which reversibly inhibits pMMO. This phenomenon 
has been studied for pMMO from M. trichosporium OB3b21. In support of this explanation, catalase 
prevents inhibition on addition of excess copper, with maximal activity still observed at 2–3 equiv. 
(Supplementary Fig. 1b). 
To probe the coordination environment of copper in pMMO, we collected X-ray absorption 
spectroscopic (XAS) data. As-isolated pMMO is a mixture of Cu(I) and Cu(II) as shown by both a 
1s → 4p transition and a weak 1s → 3d feature22 in the near-edge spectra (Supplementary Fig. 2). 
Apo-pMMO reconstituted with 3 equiv. of CuSO4 and treated with duroquinol to mimic the activity 
assay conditions has a stronger Cu(I) 1s → 4p transition consistent with the presence of reductant 
(Supplementary Fig. 2). Fourier transforms (Fig. 4b, d) of the extended X-ray absorption fine 
structure (EXAFS) data (Fig. 4a, c) for both samples show two scattering interactions corresponding 
to nearest-neighbour ligands at approximately 2 Å and 2.5 Å . Long-range ligand scattering (>3 Å) is 
also evident. The as-isolated pMMO EXAFS  were best fitted with two Cu–O/N environments at 
1.92 Å and 2.09 Å and a Cu–Cu interaction centred at 2.66 Å. The reconstituted pMMO EXAFS 
were best fitted with a single set of O/N ligands at 1.95 Å. Most important, there was a significant 
improvement in fit when a Cu–Cu scattering environment centred at 2.53 Å was included 
(Supplementary Table 2). Debye–Waller factors, which are measures of the metal–ligand bond 
disorder, were high in both Cu–Cu interaction simulations (>5.5 × 10−3 Å2), whereas the coordination 
numbers were consistently low (≤0.25). These results suggest either a near-stoichiometric 
population of distinct, but non-resolvable, Cu–Cu interactions with destructively overlapping 
scattering centred at 2.66 Å and 2.53  or low populations (less than 25%) of bound copper 
coordinated in a multinuclear cluster. Regardless, restoration of activity on copper addition is 
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accompanied by formation of a copper cluster, which is most likely the dinuclear copper centre 
observed in the crystal structures6,10. 
Possible locations for the active site in M. capsulatus (Bath) include the two copper centres in the 
soluble regions of pmoB, the intramembrane zinc site and the intramembrane hydrophilic patch 
proposed to contain a trinuclear copper site (Fig. 1)11. We cloned and expressed in Escherichia coli 
several proteins corresponding to the soluble cupredoxin domains of the pmoB subunit. These 
proteins include the N-terminal cupredoxin domain (spmoBd1, residues 33–172), the C-terminal 
cupredoxin domain (spmoBd2, residues 265–414) and both domains tethered by a Gly-Lys-Leu-Gly-
Gly-Gly linker, which replaces the two transmembrane helices (spmoB) (Fig. 1). All ligands to the 
two copper centres are contained within spmoBd1, although the mononuclear site lies at the domain 
interface.  
These recombinant proteins were refolded from solubilized inclusion bodies in the presence of 
CuSO4. Copper analysis by the bicinchoninic-acid method23 indicates the presence of 2.84 ± 0.66 
copper ions per protein for spmoB, 1.59 ± 0.84 copper ions per protein for spmoBd1 and 0.24 ± 0.09 
copper ions per protein for spmoBd2 (Fig. 2b). These values, which are an average from at least six 
independent refolding experiments, are consistent with the crystal structure of M. capsulatus (Bath) 
pMMO6, in which spmoB binds three copper ions and spmoBd2 binds no copper ions. Despite the 
excess of copper present during the refolding procedure, we do not observe the binding of 
approximately ten copper ions to spmoBd2 reported previously16. Refolding of spmoB in the 
presence of iron yields 0.17 ± 0.1 iron ions per protein.  
The spmoBd1 protein is extremely unstable, probably owing to the removal of spmoBd2. In the M. 
capsulatus (Bath) structure6, the interface between the two soluble domains is extensive, with a 
buried surface area of ~1400 Å2 for each chain. The loop region connecting dicopper ligand His 33 
with monocopper ligand His 48 is heavily involved in this interface, with a number of hydrogen 
bonds (Supplementary Fig. 3a) and hydrophobic contacts with residues from the C-terminal 
cupredoxin domain. Increased flexibility on disruption of all these interactions probably affects both 
copper centres and accounts for the reduced copper binding by spmoBd1. 
In spite of loading with Cu(II), and possibly owing to photoreduction, the X-ray absorption near-
edge spectrum of spmoB (Supplementary Fig. 2) is typical of three- to four-coordinate Cu(I) on the 
basis of the low intensity of the 1s → 4p transition, the overall edge structure and the lack of any 
discernible 1s → 3d feature. The EXAFS for spmoB (Fig. 4e, f) were best fitted with a Cu–O/N 
environment at 1.95 Å and a Cu–Cu interaction at 2.53 Å, the inclusion of which significantly 
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improved the fit (Supplementary Table 2). The combined copper binding and XAS data indicate that 
spmoB can assemble copper centres similar to those in pMMO. 
To determine whether the copper active site is located within spmoB, we performed activity assays. 
The spmoB protein is indeed active and can oxidize propylene with a specific activity of 
30.2 ± 10.5 nmol propylene oxide µmol−1 min−1, as compared with 51.1 ± 11.3 nmol propylene 
oxide µmol−1 min−1 for as-isolated, membrane-bound pMMO measured under similar experimental 
conditions (Fig. 5a). Some activity is also detected for spmoBd1, 8.1 ± 3.7 nmol propylene 
oxide µmol−1 min−1, whereas spmoBd2 is inactive. No activity is detected for spmoB refolded in the 
presence of iron. Although propylene epoxidation is routinely used for measuring MMO activity, the 
bond dissociation energies of the C=C bond in propylene (63 kcal mol−1) and the C–H bond in 
methane (104 kcal mol−1) differ significantly. Therefore, we also tested the ability of spmoB to 
oxidize methane to methanol. Under similar experimental conditions, the specific activity of as-
isolated pMMO is 325.1 nmol methanol µmol−1 min−1 and that of spmoB is 203.1 ± 20.2 nmol 
methanol µmol−1 min−1 (Fig. 5b). Consistent with the trend observed for propylene epoxidation 
activity, spmoBd1 has a specific activity of 19.3 ± 4.7 nmol methanol µmol−1 min−1 and spmoBd2 is 
inactive. The reduced activity for spmoBd1 is consistent with increased lability of the copper sites on 
removal of spmoBd2. These combined activity data indicate that the pMMO copper active site is 
located within spmoB, and rule out the possibility of the active site being a di-iron centre located at 
the crystallographic zinc site17 or a trinuclear copper centre located at the intramembrane 
hydrophilic patch12. In addition, the active site is not located in the pmoA subunit as suggested by 
radio-labelling experiments with the suicide substrate acetylene24,25. 
To pinpoint the active-site location within spmoB, we generated site-specific variants. These 
variants were designed to disrupt binding at the mononuclear copper site (spmoB_H48N), the 
dinuclear copper site (spmoB_H137,139A) and both copper sites (spmoB_H48N_H137,139A). 
Proteins were refolded and the copper content was measured using the same procedures as for 
spmoB (Fig. 2b). The spmoB_H48N variant (asparagine was selected to mimic the site in M. 
trichosporium OB3b pMMO10) binds 1.86 ± 0.52 copper ions per protein, consistent with elimination 
of the mononuclear site. The spmoB_H137,139A variant binds 0.73 ± 0.15 copper ions per protein, 
suggesting that the dinuclear copper site has been abolished and the mononuclear copper site 
remains intact. The spmoB_H48N_H137,139A variant still binds some copper, 0.81 ± 0.36 copper 
ions per protein, as does a quadruple mutant in which His 33 is changed to alanine. The 
spmoB_H48N_H137,139A variant refolded in the presence of iron binds 0.51 ± 0.14 iron ions per 
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protein. This metal binding by spmoB_H48N_H137,139A is probably nonspecific and raises the 
possibility that some fraction of the copper in spmoB_H48N and spmoB_H137,139A is also bound 
adventitiously.  
The copper coordination environments in spmoB_H48N and spmoB_H137,139A were further 
investigated by X-ray absorption spectroscopy. These two samples contain a mixture of Cu(I) and 
Cu(II) as shown by both a discernible 1s → 4p transition and a weak 1s → 3d feature 
(Supplementary Fig. 2). The EXAFS for both variants were best fitted with a Cu–O/N ligand 
environment at 1.96 Å. For spmoB_H48N, inclusion of a Cu–Cu environment at 2.52 Å improved the 
fit significantly (Fig. 4g, h and Supplementary Table 2). However, simulations to the second-shell 
for spmoB_H137,139A were improved using carbon as a ligand rather than copper, as suggested by 
the lower F′ (number of degrees of freedom weighted deviation between empirical and theoretical 
spectra) value for this fit (Fig. 4i, j and Supplementary Table 2). Thus, it is probable that this 
double mutant does not contain a dinuclear copper centre. 
Each variant was then tested for propylene epoxidation and methane oxidation activities (Fig. 5). 
Only the spmoB_H48N variant was active, with a propylene epoxidation activity of 2.3 ± 0.4 nmol 
propylene oxide µmol−1 min−1 and a methane oxidation activity of 14.8 ± 9.2 nmol 
methanol µmol−1 min−1. Because removal of the mononuclear copper site does not abolish activity, it 
cannot be the active site. By contrast, spmoB_H137,139A and spmoB_H48N_H137,139A show no 
activity (Fig. 5). These activity results combined with the EXAFS data indicate that the dinuclear 
copper centre in the pmoB subunit is required for substrate oxidation by pMMO. The dicopper site 
may not be fully occupied in spmoB_H48N, owing to the presence of adventitious copper, resulting 
in decreased activity. The activity may be further impaired by the mutation at the monocopper site, 
which probably imposes some reorganization on the domain interface (Supplementary Fig. 3a). 
These two considerations could reasonably account for the ~5% activity measured for the 
spmoB_H48N variant (Fig. 5). The location of the dicopper centre in the pMMO structure (Fig. 1) is 
consistent with some reduction in activity on isolation of spmoB. A number of pmoB residues 
adjacent to the dicopper centre interact with residues from the pmoC subunit (Supplementary Fig. 
3b). Removing these interactions probably imparts additional flexibility at the dicopper centre. 
Our work shows that pMMO is a copper enzyme and that the active site is located in the N-
terminal soluble domain of the pmoB subunit at the site of the crystallographic dicopper centre. 
Neither the proposed intramembrane di-iron centre17 nor the proposed intramembrane tricopper 
centre12 is the active site. The copper stoichiometry, XAS and activity data are most consistent with 
a dicopper, rather than a tricopper, active site. Additional support comes from computational studies 
Oxidation of methane by a biological dicopper centre |  R. Balasubramanian, et. al 
DIGITALCOMMONS@WSU  |  2010 8
of methane activation by bis(µ-oxo) dicopper species26 and reports of direct methane oxidation by 
mono-(µ-oxo) dicopper cores in zeolites27. If spmoB can do the chemistry, it is puzzling why pMMO is 
a membrane protein. It is possible that substrate entry occurs through the lipid bilayer. The 
increased solubility of methane in the membrane28,29 would provide a high local concentration. The 
methanol product probably exits through the soluble regions because the next metabolic enzyme, 
methanol dehydrogenase, is periplasmic30. The transmembrane regions could also shuttle electrons 
to the active site and might have other undiscovered activities. Given that the spmoB proteins have 
less activity than pMMO and that as-isolated pMMO has lower activity than whole cells17, 
understanding how the additional subunits and trimeric structure enhance the function is an 
important issue. 
METHODS 
Growth of  M. capsulatus (Bath) 
M. capsulatus (Bath) was cultivated as described previously9, with a few modifications. Briefly, 
12 l of nitrate mineral salts media was supplemented with a trace-element solution, 50 µM CuSO4 
and 80 µM FeEDTA. The pH of the culture was maintained at 6.8 using a 100 mM phosphate buffer. 
Adjustments to the pH during growth were made using NaOH and H2SO4. Before growth, methane 
gas was bubbled through the media for ~30 min. Approximately 5–10 g of highly active cell paste 
stock was used as the inoculum after resuspension in sterile nitrate mineral salts media at 45 °C. 
Fermentations were conducted at 45 °C with an air:methane gas ratio of 4:1 and a constant 
agitation of 300 r.p.m. Cells were harvested at mid-exponential phase (D600 nm = 5–7) and centrifuged 
for 10 min at 8,000g. Pelleted cells were washed by resuspension in 25 mM PIPES (pH 6.8), re-
centrifuged, flash frozen in liquid nitrogen and stored at −80 °C. 
Isolation of  pMMO-containing membranes 
Frozen cells were resuspended in lysis buffer (25 mM PIPES (pH 6.8), 250 mM NaCl) and 
sonicated on ice. Cell debris was removed by centrifugation at 20,000g for 1.5 h. The lysate was then 
ultracentrifuged at 160,000g for 1 h to pellet intracytoplasmic membranes. These membranes were 
resuspended in fresh lysis buffer using a Dounce homogenizer. Ultracentrifugation and 
resuspension were repeated three times to remove contaminating soluble proteins. SDS–
polyacrylamide gel electrophoresis (PAGE) analysis of the as-isolated membranes showed that the 
predominant component is pMMO. The homogenized crude membranes at ~10–20 mg ml−1 were 
flash frozen in liquid nitrogen and stored at −80 °C. 
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Preparation of  apo-pMMO 
Active as-isolated pMMO membranes were incubated with 50 mM MOPS (pH 8.0) and 250 mM 
NaCl supplemented with a tenfold molar excess (based on copper concentration) of KCN and freshly 
prepared sodium ascorbate. The addition of ascorbate did not affect the pH of the solution. After a 1-
h incubation at room temperature (~25 °C) with stirring, the solution was ultracentrifuged at 
160,000g for 30 min to pellet the pMMO membranes. The apo-pMMO membranes were resuspended 
and washed three times with fresh lysis buffer to remove excess KCN and ascorbate. Cyanide 
treatment does not alter the integrity of the subunits according to SDS–PAGE. Moreover, apo-
pMMO stored at 4 °C has higher activity on copper reactivation than as-isolated pMMO stored at 
4 °C for the same time period. This observation suggests that the strict anaerobic protocols used by 
other researchers17 might serve to protect against oxidative damage caused by excess metal ions. 
 
Cloning of  spmoB, spmoBd1 and spmoBd2 
Three constructs of the soluble domain of pmoB (spmoB) were generated: spmoBd1 (residues 33–
172), spmoBd2 (residues 265–414) and spmoB (residues 33–172 and residues 265–414 connected by 
a Gly-Lys-Leu-Gly-Gly-Gly linker rather than by the two transmembrane helices) (Fig. 1). This 
linker was designed by inspection of the pMMO structure, and the glycine residues were selected to 
impart flexibility. Primers spmoBd1F (5′-GGA ATT CCA TAT GCA CGG TGA GAA ATC GCA GG-3′) 
and spmoBd1R (5′-GTG ATC CAA GCT TTC CGG TGG TGA CGG GGT TGC GAA-3′) were used to 
amplify spmoBd1 from M. capsulatus (Bath) genomic DNA. The NdeI andHindIII-digested PCR 
product encoding spmoBd1 was then ligated into a NdeI andHindIII-digested pET21b(+) vector 
(Novagen). Primers spmoBd2F (5′-GAG AAG CAA GCT TGG AGG AGG ACA GGC CGC CGG CAC 
CAT GCG TGG-3′) and spmoBd2R1 (5′-GAG ATC CCA AGC TTA CAT GAA CGA CGG GAT CAG 
CGG-3′) were used to amplify spmoBd2. The pET21b(+)-spmoBd2 vector was generated by ligation 
of the PCR product encoding spmoBd2 at the NdeI–HindIII sites. To generate the spmoB construct, 
HindIII-digested PCR product encoding spmoBd2 amplified using primers spmoBd2F (5′-GAG AAG 
CAA GCT TGG AGG AGG ACA GGC CGC CGG CAC CAT GCG TGG-3′) and spmoBd2R2 (5′-GAG 
ATC CCA AGC TTA CAT GAA CGA CGG GAT CAG CGG-3′) was inserted into the HindIII-digested 
pET21b(+)-spmoBd1 vector. Authenticity of the coding sequences for all constructs was verified by 
DNA sequencing. There is a silent mutation in the spmoB DNA sequence at position 1,076 that 
changes C to G (ACC-to-ACG coding for Thr). The site-directed variants spmoB_H48N, 
spmoB_H137,139A and spmoB_H48N_H137,139A were generated using either a traditional single 
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mutagenesis kit or a multisite-directed mutagenesis kit from Stratagene and verified by DNA 
sequencing. 
 
Protein expression, purification and refolding 
For protein expression, plasmids were transformed into either the BL21(DE3) or the Rosetta (DE3) 
strain of E. coli. Ten millilitres of an overnight culture of freshly transformed cells were transferred 
to 1 l of LB supplemented with 50 µg ml−1 ampicillin. After reaching an attenuance of D600 nm = 0.6 at 
37 °C, 0.5 mM IPTG was added and followed by 4 h of post-induction growth. All the expression 
constructs tested produced proteins that formed inclusion bodies (Supplementary Fig. 4). 
Alterations to the growth temperature, incubation times, inducer concentrations and growth media 
had no effect on the protein solubility. Cells from 4 l of growth were collected by centrifugation at 
5,000g for 10 min, washed and resuspended in 200 ml of 20 mM TrisCl (pH 8.0) and 50 mM NaCl, 
flash frozen in liquid nitrogen and stored at −20 °C until further processed. 
Frozen cells were thawed in lukewarm water and lysed by a 10-min sonication cycle of 10 s on/30 s 
off pulses on ice at 50% output power. Inclusion bodies were separated from cell debris and other 
soluble proteins by centrifuging for 30 min at 3,000g. The inclusion bodies were then washed three 
times with 20 mM TrisCl (pH 8.0), 50 mM NaCl and 1.0% Triton X-100, and once more with the 
same buffer lacking Triton X-100. Inclusion bodies isolated using this procedure were >90% pure 
and required no additional purification steps (Supplementary Fig. 4). Typically, 1–3 g of inclusion 
bodies can be isolated from 1 l of cell culture. Purified inclusion bodies were solubilized in 8 M urea 
(20 ml urea per 1 g). This mixture was left stirring at room temperature for 1 h and then 
centrifuged at 15,000g for 30 min at room temperature. Urea-solubilized inclusion bodies were 
aliquoted and stored at –80°C for further use. 
All attempts to express even partly soluble protein were unsuccessful. Therefore, a refolding 
procedure was developed. Urea-solubilized inclusion bodies were diluted to ~5 mg ml−1 protein 
concentration. Protein refolding was performed using a stepwise dialysis procedure against buffers 
containing a stepwise reduction in the urea concentration. Each dialysis was performed for at least 
3 h. After a 3-h dialysis against 7 M urea, the protein was dialysed against 6 M urea for 3 h and 
then against 5 M urea for 3 h, and so forth. After dialysis against a buffer containing 0.5 M urea, at 
least two rounds of dialysis were performed against a buffer containing either 20 mM TrisCl (pH 
8.0) or 20 mM PIPES (pH 7.0), and 250 mM NaCl (no urea). On the basis of SDS–PAGE band 
intensities, we estimate that about 0.2–5% of the total protein was folded after this procedure. 
Precipitates were removed by centrifugation at 20,000g for 10 min at 4 °C using a tabletop 
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centrifuge. The spmoBd1 variant was generally less stable and more susceptible to precipitation 
during these procedures. 
Circular dichroism spectra were recorded on a JASCO J-715 spectrometer using a 2-mm-path-
length quartz cuvette. Proteins were diluted to ~1–2 µM in a buffer of 20 mM potassium phosphate 
(pH 7.5) and 20 mM potassium fluoride. An average of five scans was collected at 20 °C with 1-nm 
resolution. Laccase from Trametes versicolor (Sigma Aldrich) was used as a model cupredoxin. All 
the spmoB variants seem folded and have similar secondary-structure properties, suggesting that 
the mutations do not perturb the overall structure (Supplementary Fig. 5). 
Folding was further assessed by analytical size exclusion chromatography on a 21-ml prepacked 
Superdex G75 column equilibrated with 20 mM PIPES (pH 7.0) and 150 mM NaCl for at least three 
column volumes. Recombinant proteins were injected in 0.5-ml aliquots and the molecular masses 
(Supplementary Table 3) were determined using the following standards: blue dextran (void 
volume), 2 MDa; aldolase, 158 kDa; concanavalin, 75 kDa; albumin, 66 kDa; ovalbumin, 43 kDa; 
chymotrypsinogen, 25 kDa; RNase, 13.7 kDa; aprotinin, 6.5 kDa. None of the proteins seem to form 
trimers, suggesting that the transmembrane regions of pMMO drive oligomerization. 
Copper loading of recombinant proteins 
The spmoB protein contains the ligands to the two copper sites observed in the M. capsulatus 
(Bath) crystal structure (Fig. 1). Complete precipitation occurred on copper addition to refolded 
spmoB. Therefore, a refolding procedure in the presence of copper was developed and used for all 
spmoB variants. The 6 M urea dialysis buffer included 1 mM CuSO4, and the stepwise reduction in 
urea concentration was accompanied by a reduction in copper concentration. Excess copper was then 
removed from Cu(II)-refolded proteins by dialysis against a buffer containing either 20 mM TrisCl 
(pH 8.0) or 20 mM PIPES (pH 7.0), and 250 mM NaCl, with no CuSO4 or urea. Proteins refolded 
following this procedure contained no detectable iron. For refolding of spmoB and its variants in the 
presence of iron, 1 mM Fe(NH4)2(SO4)2 was added during dialysis instead of CuSO4. All other 
procedures were identical to those used for refolding in the presence of copper. 
 
Determination of  metal content 
The copper contents of spmoB variants were measured using the bicinchoninic-acid (BCA) 
method23. Standards of 0–60 µM copper were prepared by diluting commercially available copper 
atomic absorption spectroscopy standard solutions (Sigma Aldrich) in water. The Cu(I)–BCA 
complex has absorbance peaks at 360 and 562 nm. The iron contents of spmoB variants were 
determined using the ferrozine assay31. A solution containing 150 µl 1 M HCl, 150 µl freshly 
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prepared 1.7 mM ascorbate and 250 µl 0.1% ferrozine (Acros Organics) prepared in 50% ammonium 
acetate was added to 150 µl protein. The reaction mixture was incubated at 30 °C for 15 min, 
centrifuged and the absorbance at 570 nm of the supernatant measured. A standard curve using 
iron atomic absorption standard (Aldrich) was generated for a 0–40 µM iron concentration range. 
The copper, iron and zinc contents of as-isolated pMMO membranes and apo-pMMO membranes 
were determined by inductively coupled plasma optical emission spectroscopy (ICP–OES) using a 
Varian Vista-MPX charge-coupled-device simultaneous ICP–OES instrument in the Integrated 
Molecular Structure Education and Research Center at Northwestern University. Samples were 
digested in 5% trace-metal grade (TMG) nitric acid before analysis. Standard curves were generated 
from atomic absorption standards diluted in 5% nitric acid (TMG). All samples were measured in 
triplicate. Protein concentrations were determined using either Bradford reagent or detergent-
compatible Bio-Rad DC protein assays. Alternatively, estimated extinction coefficients for the 
absorbance at 280 nm were used for the spmoB variants. 
 
Propylene epoxidation assay 
pMMO activity was assessed by the propylene epoxidation assay using duroquinol as the 
reductant9. In a typical assay, solid duroquinol is added to 50 µl as-isolated pMMO in a septa-sealed 
3-ml reaction vial such that the final concentration of duroquinol is 0.9–1.1 M. The assay is then 
initiated by replacing 2 ml of the headspace gas with propylene and the vial is shaken in a 45 °C 
water bath for 3 min. The amount of propylene oxide produced is measured by injecting 250 µl of 
headspace gas onto a Porapak Q column (Supelco) using a Hewlett Packard 5890A gas 
chromatograph. Quantitation is performed by comparison with pure propylene oxide standards 
(Sigma Aldrich). Typical activity values were between 50–200 nmol propylene oxide mg−1 min−1  
(Supplementary Table 1). For metal-reconstituted-activity assays, apo-pMMO was incubated with 
varying molar equivalents of CuSO4 and/or Fe(NH4)2(SO4)2 for 30 min and measurements performed 
as above. The CuSO4 solution (280 p.p.m.) contained <0.02 p.p.m. iron, so addition of 1 equiv. of 
copper would correspond to ~10−7 equiv. of iron. The iron content of apo-pMMO reconstituted with 
copper did not increase. The titration results shown in Fig. 3 were reproduced more than four 
times. For experiments with catalase, commercial enzyme (Sigma Aldrich) was added at a 
concentration of ~1 mg ml−1 to samples reconstituted with more than 2–3 equiv. of copper 
(Supplementary Fig. 1b).  
For the spmoB variants, the propylene epoxidation assay was performed with several 
modifications. Briefly, protein sample volumes were 350 µl and headspace air (2.5 ml) was replaced 
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with 2.0 ml propylene and 0.5 ml air. The reaction mixture was incubated in the 45 °C shaking 
water bath for at least 1 h. A longer incubation time for spmoB was required to accurately measure 
product formation. For comparisons of the spmoB activity with that of as-isolated pMMO, the 
pMMO assay was also carried out for 1 h (Fig. 5). All activity assays were performed in duplicate. 
To account for the differences in molecular masses when comparing activities of pMMO (~100 kDa) 
with those of spmoB and its variants (~16–32 kDa), the activities of spmoB and its variants are 
reported per mole instead of per milligram. 
 
Methane oxidation assay 
Methanol production by both pMMO and the spmoB variants was measured by gas 
chromatography using a Rt-Q-BOND capillary column (Restek). The procedure for the propylene 
epoxidation assay was used with the following modifications. Methane (2 ml) was added to the 
headspace instead of propylene as the substrate. The reaction was performed for 3 min at 45 °C for 
pMMO (Fig. 3) and for at least 1 h at 45 °C for spmoB and its variants (Fig. 5). For comparisons of 
the spmoB activity with that of as-isolated pMMO, the pMMO assay was also carried out for 1 h 
(Fig. 5). After this procedure, the samples were heated to 85 °C for 10 min to stop the reaction, and 
cooled on ice. Samples were then centrifuged briefly and 3 µl of the clear supernatant injected onto 
the capillary column at a constant oven temperature of 75 °C. Quantitation was performed using 
standard curves generated by analysing methanol standards (Sigma Aldrich; spectrophotometric 
grade >99%). For both propylene epoxidation and methane oxidation assays, numerous control 
assays in which duroquinol, substrate or enzyme was eliminated systematically from the reaction 
mixture were performed. 
 
X-ray absorption spectroscopy 
XAS data were collected on the following five samples: as-isolated pMMO (sample 1), apo-pMMO 
reconstituted with CuSO4 in the presence of duroquinol (sample 2), spmoB (sample 3), spmoB_H48N 
(sample 4) and spmoB_H137,139A (sample 5). As-isolated and apo-pMMO membranes were 
ultracentrifuged and resuspended in 25 mM PIPES (pH 6.8), 250 mM NaCl and 50% glycerol before 
loading into Kapton-tape-wrapped Lucite cells and flash freezing in liquid nitrogen. The samples 
were stored in liquid nitrogen until data collection was performed. For reconstituted pMMO 
membranes, apo samples were incubated with 3 equiv. of CuSO4 for 30 min followed by addition of 
excess duroquinol, ultracentrifugation, resuspension, cell loading and freezing. The final copper 
concentrations were 0.7–2 mM. For spmoB and its variants, all samples were prepared in 10 mM 
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TrisCl (pH 8.0), 250 mM NaCl and 50% glycerol. The final copper concentrations were 0.3–0.9 mM. 
All XAS results were reproduced using two independent samples. 
XAS data were collected at the SSRL on beamline 9-3 using a Si(220) double-crystal 
monochromator equipped with a harmonic rejection mirror. Samples were maintained at 10 K using 
an Oxford Instruments continuous-flow liquid helium cryostat. Protein fluorescence excitation 
spectra were collected using a 30-element germanium solid-state array detector. A nickel filter 
(0.3 µm wide) was placed between the cryostat and the detector to filter scattering fluorescence not 
associated with protein copper signals. XAS spectra were measured using 5-eV steps in the pre-edge 
region (8,750–8,960 eV), 0.25-eV steps in the edge region (8,986–9,050 eV) and 0.05 Å−1 increments 
in the EXAFS region (to k = 13.0 Å−1), integrating from 1 s to 20 s in a k3-weighted manner for a 
total scan length of approximately 45 min. X-ray energies within the protein spectra were internally 
calibrated by simultaneously collecting copper foil absorption spectra; the first inflection point in the 
copper foil spectra was assigned as 8,980 eV. Each fluorescence channel of each scan was examined 
for spectral anomalies before averaging, and spectra were closely monitored for photoreduction. The 
represented data are the average of seven or eight scans. 
XAS data were processed using the Macintosh OS X version of the EXAFSPAK program suite32 
integrated with the FEFF 7 software33 for theoretical model generation. Data reduction followed a 
previously published protocol for a spectral resolution in bond lengths of 0.13 Å (ref. 8). EXAFS 
fitting analysis was performed on raw/unfiltered data. Protein EXAFS data were fitted either using 
single-scattering FEFF 7 theoretical models, calculated for carbon, oxygen, sulphur and copper 
coordination to simulate copper-ligand environments, or a multiple-scattering imidazole model, and 
values for the scale factors (Sc) and Eo calibrated by fitting crystallographically characterized copper 
model compounds, as outlined previously8. Criteria for judging the best-fit EXAFS simulations used 
both the lowest mean square deviation between data and fit corrected for the number of degrees of 
freedom (F′)34 and reasonable Debye–Waller factors (σ2 < 0.006 Å2). First-shell fits with a single set 
of O/N ligands gave significantly better F′ values than fits with a single Cu–S or Cu–Cu 
environment for all samples. Long-range scattering (>3 Å) evident for all five samples could not be 
fitted with a multiple-scattering Cu-imidazole model, as shown by the large F′ values for these fits 
(Supplementary Table 2, fits 1.3, 2.3, 3.3, 4.3 and 5.3). 
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METHODS SUMMARY 
We cultivated M. capsulatus (Bath) as described previously9, with minor modifications. Cells were 
lysed by sonication and ultracentrifuged with multiple washing/homogenization steps to obtain 
pMMO-containing membranes. Metals were removed from as-isolated pMMO by treatment with 
KCN. Genes encoding spmoBd1 (residues 33–172), spmoBd2 (residues 265–414) and spmoB 
(residues 33–172 and residues 265–414 connected by a Gly-Lys-Leu-Gly-Gly-Gly linker instead of 
the two transmembrane helices) were amplified by PCR and cloned into a pET21b(+) expression 
vector. We generated site-directed variants using commercial kits. All proteins expressed as 
inclusion bodies, which were centrifuged and treated with Triton X-100 to obtain >90% pure 
samples. Purified inclusion bodies were solubilized with urea and refolded by a stepwise dialysis 
procedure in the presence of CuSO4. Folding was assessed by circular dichroism spectroscopy and 
size exclusion chromatography. We determined metal content by the bicinchoninic-acid method23 or 
by inductively coupled plasma optical emission spectroscopy. Propylene epoxidation and methane 
oxidation activities were measured by gas chromatography using Porapak Q packed columns and 
Rt-Q-BOND capillary columns, respectively. XAS data were collected at the Stanford Synchrotron 
Radiation Laboratory on beamline 9-3 (ref. 8). 
 
Supplementary Information is linked to the online version of the paper at www.nature.com/nature. 
Acknowledgements  
This work was supported by US National Institutes of Health (NIH) grants GM070473 (A.C.R.) 
and DK068139 (T.L.S.). Portions of this research were carried out at the Stanford Synchrotron 
Radiation Laboratory (SSRL). The SSRL is a national user facility operated by Stanford University 
on behalf of the US Department of Energy, Office of Basic Energy Sciences. The SSRL Structural 
Molecular Biology Program is supported by the Department of Energy, Office of Biological and 
Environmental Research, and by the NIH, National Center for Research Resources, Biomedical 
Technology Program. 
Author Contributions  
R.B., S.M.S., S.R. and L.A.Y. performed experiments. R.B., S.M.S., S.R., T.L.S. and A.C.R. 
contributed to experimental design, data analysis and manuscript preparation. 
 
Oxidation of methane by a biological dicopper centre |  R. Balasubramanian, et. al 
DIGITALCOMMONS@WSU  |  2010 16
Author Information   
Reprints and permissions information is available at www.nature.com/reprints. The authors 
declare no competing financial interests. Correspondence and requests for materials should be 
addressed to T.L.S. (tstemmle@med.wayne.edu) or A.C.R. (amyr@northwestern.edu). 
 
References 
1. Hermans, I., Spier, E. S., Neuenschwander, U., Turra, N. & Baiker, A. Selective oxidation catalysis: 
opportunities and challenges. Top. Catal. 52, 1162–1174 (2009). 
2. Arakawa, H. et al. Catalysis research of relevance to carbon management: progress, challenges, and 
opportunities. Chem. Rev. 101, 953–996 (2001). 
3. Que, L. & Tolman, W. B. Biologically inspired oxidation catalysis. Nature 455, 333–340 (2008). 
4. Merkx, M. et al. Dioxygen activation and methane hydroxylation by soluble methane monooxygenase: a 
tale of two irons and three proteins. Angew. Chem. Int. Ed. 40, 2782–2807 (2001). 
5. Hakemian, A. S. & Rosenzweig, A. C. The biochemistry of methane oxidation. Annu. Rev. Biochem. 76, 
223–241 (2007). 
6. Lieberman, R. L. & Rosenzweig, A. C. Crystal structure of a membrane-bound metalloenzyme that 
catalyses the biological oxidation of methane. Nature 434, 177–182 (2005). 
7. Balasubramanian, R. & Rosenzweig, A. C. Structural and mechanistic insights into methane oxidation 
by particulate methane monooxygenase. Acc. Chem. Res. 40, 573–580 (2007). 
8. Lieberman, R. L. et al. Characterization of the particulate methane monooxygenase metal centers in 
multiple redox states by X-ray absorption spectroscopy. Inorg. Chem. 45, 8372–8381 (2006). 
9. Lieberman, R. L. et al. Purified particulate methane monooxygenase from Methylococcus capsulatus 
(Bath) is a dimer with both mononuclear copper and a copper-containing cluster. Proc. Natl Acad. Sci. 
USA 100, 3820–3825 (2003).  
10. Hakemian, A. S. et al. The metal centers of particulate methane monooxygenase from Methylosinus 
trichosporium OB3b. Biochemistry 47, 6793–6801 (2008). 
11. Rosenzweig, A. C. The metal centres of particulate methane monooxygenase. Biochem. Soc. Trans. 36, 
1134–1137 (2008). 
12. Chan, S. I. & Yu, S. S. F. Controlled oxidation of hydrocarbons by the membrane-bound methane 
monooxygenase: the case for a tricopper cluster. Acc. Chem. Res. 41, 969–979 (2008). 
13. Chen, K. H.-C. et al. The copper clusters in the particulate methane monooxygenase (pMMO) from 
Methylococcus capsulatus (Bath). J. Chin. Chem. Soc. 51, 1081–1098 (2004). 
14. Nguyen, H.-H. T. et al. X-ray absorption and EPR studies on the copper ions associated with the 
particulate methane monooxygenase from Methylococcus capsulatus (Bath). Cu(I) ions and their 
implications. J. Am. Chem. Soc. 118, 12766–12776 (1996). 
Oxidation of methane by a biological dicopper centre |  R. Balasubramanian, et. al 
DIGITALCOMMONS@WSU  |  2010 17
15. Chan, S. I. et al. Redox potentiometry studies of particulate methane monooxygenase: support for a 
trinuclear copper cluster active site. Angew. Chem. Int. Ed. 46, 1992–1994 (2007). 
16. Yu, S. S. F. et al. The C-terminal aqueous-exposed domain of the 45 kDa subunit of the particulate 
methane monooxygenase in Methylococcus capsulatus (Bath) is a Cu(I) sponge. Biochemistry 46, 
13762–13774 (2007). 
17. Martinho, M. et al. Mössbauer studies of the membrane-associated methane monooxygenase from 
Methylococcus capsulatus Bath: evidence for a diiron center. J. Am. Chem. Soc. 129, 15783–15785 
(2007). 
18. Choi, D. W. et al. The membrane-associated methane monooxygenase pMMO and pMMO-
NADH:quinone oxidoreductase complex from Methylococcus capsulatus Bath. J. Bacteriol. 185, 5755–
5764 (2003). 
19. Kitmitto, A., Myronova, N., Basu, P. & Dalton, H. Characterization and structural analysis of an active 
particulate methane monooxygenase trimer from Methylococcus capsulatus (Bath). Biochemistry 44, 
10954–10965 (2005). 
20. Yu, S. S.-F. et al. Production of high-quality particulate methane monooxygenase in high yields from 
Methylococcus capsulatus (Bath) with a hollow-fiber membrane bioreactor. J. Bacteriol. 185, 5915–5924 
(2003). 
21. Miyaji, A., Suzuki, M., Baba, T., Kamachi, T. & Okura, I. Hydrogen peroxide as an effecter on the 
inactivation of particulate methane monooxygenase under aerobic conditions. J. Mol. Catal. B 57, 211–
215 (2009). 
22. Kau, L.-S., Spira-Solomon, D. J., Penner-Hahn, J. E., Hodgson, K. O. & Solomon, E. I. X-ray absorption 
edge determination of the oxidation state and coordination number of copper. Application to the type 3 
site in Rhus vernicifera laccase and its reaction with oxygen. J. Am. Chem. Soc. 109, 6433–6442 (1987). 
23. Yatsunyk, L. A. & Rosenzweig, A. C. Copper(I) binding and transfer by the N-terminus of the Wilson 
disease protein. J. Biol. Chem. 282, 8622–8631 (2007). 
24. Prior, S. D. & Dalton, H. Acetylene as a suicide substrate and active site probe for methane 
monooxygenase from Methylococcus capsulatus (Bath). FEMS Microbiol. Lett. 29, 105–109 (1985). 
25. Zahn, J. A. & DiSpirito, A. A. Membrane-associated methane monooxygenase from Methylococcus 
capsulatus (Bath). J. Bacteriol. 178, 1018–1029 (1996). 
26. Shiota, Y. & Yoshizawa, K. Comparison of the reactivity of bis(µ-oxo)CuIICuIII and CuIIICuIII species 
to methane. Inorg. Chem. 48, 838–845 (2009). 
27. Woertink, J. S. et al. A [Cu2O]2+ core in Cu-ZSM-5, the active site in the oxidation of methane to 
methanol. Proc. Natl Acad. Sci. USA 106, 18908–18913 (2009). 
28. Miller, K. W., Hammond, L. & Porter, E. G. The solubility of hydrocarbon gases in lipid bilayers. Chem. 
Phys. Lipids 20, 229–241 (1977). 
29. Batliwala, H., Somasundaram, T., Uzgiris, E. E. & Makowski, L. Methane-induced hemolysis of human 
erythrocytes. Biochem. J. 307, 433–438 (1995). 
Oxidation of methane by a biological dicopper centre |  R. Balasubramanian, et. al 
DIGITALCOMMONS@WSU  |  2010 18
30. Myronova, N., Kitmitto, A., Collins, R. F., Miyaji, A. & Dalton, H. Three-dimensional structure 
determination of a protein supercomplex that oxidizes methane to formaldehyde in Methylococcus 
capsulatus (Bath). Biochemistry 45, 11905–11914 (2006). 
31. Stookey, L. L. Ferrozine - a new spectrophotometric reagent for iron. Anal. Chem. 42, 779–781 (1970).  
32. George, G. N., George, S. J. & Pickering, I. J. EXAFSPAK 〈http://www-
ssrl.slac.stanford.edu/~george/exafspak/exafs.htm〉 (2001).  
33. Ankudinov, A. L. & Rehr, J. J. Relativistic calculations of spin-dependent X-ray absorption spectra. 
Phys. Rev. B 56, R1712–R1716 (1997).  
34. Riggs-Gelasco, P. J., Stemmler, T. L. & Penner-Hahn, J. E. XAFS of dinuclear metal sites in proteins 
and model compounds. Coord. Chem. Rev. 144, 245–286 (1995).  
 
 
 
 
